StockOtters
StockOttersSupply Chain Map
SAMSUNG PHARM. Co., Ltd. logo

SAMSUNG PHARM. Co., Ltd.

001360.KS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
33
Cost of Revenue
18
Gross Profit
15
Gross Margin
44.6%
Operating Income
-11
Operating Margin
-33.5%
Net Income
-11
Net Margin
-31.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-9
EBITDA Margin
-26.5%

2023

12/31/2023

Revenue
39
Cost of Revenue
22
Gross Profit
17
Gross Margin
44.2%
Operating Income
-14
Operating Margin
-34.7%
Net Income
-19
Net Margin
-47.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-16
EBITDA Margin
-41.7%

2022

12/31/2022

Revenue
39
Cost of Revenue
20
Gross Profit
18
Gross Margin
47.5%
Operating Income
-10
Operating Margin
-26.9%
Net Income
-19
Net Margin
-48.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-16
EBITDA Margin
-42.4%

2021

12/31/2021

Revenue
41
Cost of Revenue
34
Gross Profit
7
Gross Margin
16.9%
Operating Income
-14
Operating Margin
-33.0%
Net Income
-30
Net Margin
-73.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-27
EBITDA Margin
-66.4%

2020

12/31/2020

Revenue
36
Cost of Revenue
28
Gross Profit
8
Gross Margin
21.7%
Operating Income
-8
Operating Margin
-20.8%
Net Income
-30
Net Margin
-82.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-19
EBITDA Margin
-52.5%